Table of Contents
. (A-C) Determination of concentration inducing 50% inhibition of NO production using LPStreated RAW 264.7 for compounds 1-3, 5, 6, 8, 10 and 11. Figure S3 . 1 H NMR spectrum of thuwalallene A (1) in CDCl3. S6 Figure S4 . HSQC spectrum of thuwalallene A (1) in CDCl3. S6 Figure S5 . HMBC spectrum of thuwalallene A (1) in CDCl3. S7 Figure S6 . COSY spectrum of thuwalallene A (1) in CDCl3. S7 Figure S7 . NOESY spectrum of thuwalallene A (1) in CDCl3.
S8 Figure S8 . HR-APCIMS spectrum of thuwalallene A (1).
S8 Figure S9 . 1 H NMR spectrum of thuwalallene B (2) in CDCl3.
S9 Figure S10 . HSQC spectrum of thuwalallene B (2) in CDCl3.
S9 Figure S11 . HMBC spectrum of thuwalallene B (2) in CDCl3. S10 Figure S12 . COSY spectrum of thuwalallene B (2) in CDCl3. S10 Figure S13 . NOESY spectrum of thuwalallene B (2) in CDCl3. S11 Figure S14 . HR-APCIMS spectrum of thuwalallene B (2). S11 Figure S15 . 1 H NMR spectrum of thuwalallene C (3) in CDCl3. S12 Figure S16 . 13 C NMR spectrum of thuwalallene C (3) in CDCl3. S12 Figure S17 . HSQC spectrum of thuwalallene C (3) in CDCl3. S13 Figure S18 . HMBC spectrum of thuwalallene C (3) in CDCl3. S13 Figure S19 . COSY spectrum of thuwalallene C (3) in CDCl3. S14 Figure S20 . NOESY spectrum of thuwalallene C (3) in CDCl3. S14 Figure S21 . HR-APCIMS spectrum of thuwalallene C (3). S15 Figure S22 . 1 H NMR spectrum of thuwalenyne A (4) in CDCl3. S16 Figure S23 . HSQC spectrum of thuwalenyne A (4) in CDCl3. S16 Figure S24 . HMBC spectrum of thuwalenyne A (4) in CDCl3. S17 Figure S25 . COSY spectrum of thuwalenyne A (4) in CDCl3. S17 Figure S26 . NOESY spectrum of thuwalenyne A (4) in CDCl3. S18 Figure S27 . HR-APCIMS spectrum of thuwalenyne A (4). S18 Figure S28 . 1 H NMR spectrum of thuwalallene D (5) in CDCl3. S19 Figure S29 . HSQC spectrum of thuwalallene D (5) in CDCl3. S19 Figure S30 . HMBC spectrum of thuwalallene D (5) in CDCl3. S20 Figure S31 . COSY spectrum of thuwalallene D (5) in CDCl3. S20 Figure S32 . NOESY spectrum of thuwalallene D (5) in CDCl3. S21 Figure S33 . HR-APCIMS spectrum of thuwalallene D (5). S21 Figure S34 . 1 H NMR spectrum of thuwalenyne B (6) in CDCl3. S22 Figure S35 . HSQC spectrum of thuwalenyne B (6) in CDCl3. S22 Figure S36 . HMBC spectrum of thuwalenyne B (6) in CDCl3.
S23 Figure S37 . COSY spectrum of thuwalenyne B (6) in CDCl3. S23 Figure S38 . NOESY spectrum of thuwalenyne B (6) in CDCl3. S24 Figure S39 . HR-APCIMS spectrum of thuwalenyne B (6). S24 Figure S40 . 1 H NMR spectrum of thuwalenyne C (7) in CDCl3. S25 Figure S41 . HSQC spectrum of thuwalenyne C (7) in CDCl3. S25 Figure S42 . HMBC spectrum of thuwalenyne C (7) in CDCl3. S26 Figure S43 . COSY spectrum of thuwalenyne C (7) in CDCl3. S26 Figure S44 . NOESY spectrum of thuwalenyne C (7) in CDCl3. S27 Figure S45 . HR-APCIMS spectrum of thuwalenyne C (7). S27 Figure S46 . 1 H NMR spectrum of thuwalallene E (8) in CDCl3.
S28 Figure S47 . 13 C NMR spectrum of thuwalallene E (8) in CDCl3.
S28 Figure S48 . HSQC spectrum of thuwalallene E (8) in CDCl3. S29 Figure S49 . HMBC spectrum of thuwalallene E (8) in CDCl3. S29 Figure S50 . COSY spectrum of thuwalallene E (8) in CDCl3. S30 Figure S51 . NOESY spectrum of thuwalallene E (8) in CDCl3.
S30 Figure S52 . HR-APCIMS spectrum of thuwalallene E (8). S31 Figure S53 . 1 H NMR spectrum of cis-maneonene D (9) in CDCl3. S32 Figure S54 . 1 H NMR spectrum of thyrsiferol (10) in CDCl3. S32 Figure S55 . 1 H NMR spectrum of 23-acetyl-thyrsiferol (11) Figure S9 . 1 H NMR spectrum of thuwalallene B (2) in CDCl3. Figure S22 . 1 H NMR spectrum of thuwalenyne A (4) in CDCl3. Figure S28 . 1 H NMR spectrum of thuwalallene D (5) in CDCl3. Figure S34 . 1 H NMR spectrum of thuwalenyne B (6) in CDCl3. Figure S40 . 1 H NMR spectrum of thuwalenyne C (7) in CDCl3. Figure S52 . HR-APCIMS spectrum of thuwalallene E (8).
MP0677-8 #14 RT: 0.20 AV: Figure S53 . 1 H NMR spectrum of cis-maneonene D (9) in CDCl3. Figure S54 . 1 H NMR spectrum of thyrsiferol (10) in CDCl3.
ppm (f1) 1.0
